awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40539487-467C2C38-F443-425B-97BC-17B431608D02
Q40539487-467C2C38-F443-425B-97BC-17B431608D02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40539487-467C2C38-F443-425B-97BC-17B431608D02
Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia.
P2860
Q40539487-467C2C38-F443-425B-97BC-17B431608D02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40539487-467C2C38-F443-425B-97BC-17B431608D02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
123c4f6dfd39d674b942b9196b85d999548ee965
P2860
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).